Calidi Biotherapeutics (CLDI) executive compensation, 2026 proxy

Eric Poma, Chief Executive Officer, was paid $673,898 in 2025.

Filed
April 29, 2026
Annual meeting
June 12, 2026
Pay year
2025
Named executives
4
CEO total pay
$673,8982025
CEO Base Salary
$535,000Eric Poma annual base salary
CFO Base Salary
$430,000Andrew Jackson annual base salary
Former CEO Separation Pay
$0.5 millionAllan J. Camaisa compensation continuation

How Poma was paid

$673,898 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary53%Option awards40%All other compensation7%

Named executive officers

ExecutiveTotal
Eric PomaChief Executive Officer$673,898
Allan J. CamaisaDirector, Former Chief Executive Officer and Chairman of the Board$982,662
Andrew JacksonChief Financial Officer$593,965
Antonio F. SantidrianChief Scientific Officer and Head of Technical Operations$576,994

What changed and why

  • $674KEric Poma was appointed as Chief Executive Officer effective April 22, 2025, receiving total compensation of $673,898.
  • $983KAllan J. Camaisa resigned as CEO effective April 21, 2025, and received $982,662 in total compensation for the fiscal year.
  • $594KAndrew Jackson served as Chief Financial Officer and earned total compensation of $593,965 for fiscal 2025.
  • $577KAntonio F. Santidrian became an executive officer on September 3, 2025, and received total compensation of $576,994.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.